Publications

Publications

Publications

Enroll-HD is both a worldwide observational study and a clinical research platform supporting various studies and trials, with an overall objective to accelerate HD therapeutic development. Clinical data and biosamples collected in Enroll-HD and other HD studies are made available through the Enroll-HD platform to any verified researcher per the Clinical Data and Biosample Access Policy to extract as much knowledge as possible. As ever, we are enormously grateful to the thousands of participants and families around the world who selflessly give their time and energy, as well as to the dedicated staff at the clinical sites who make Enroll-HD possible.

When publishing their findings, researchers using these data and biosamples are expected to adhere to the Enroll-HD publication policy, including full acknowledgement of the individuals who contributed to the collection of the Enroll-HD data. The publications hosted here have all used the Enroll-HD datasets that are periodically made available and illustrate some of the areas of HD research that Enroll-HD is directly influencing.

If your publication that uses Enroll-HD data is not included in this gallery, or you know of a publication that should be included, then please let us know at info@chdifoundation.org. In the near future we will also be including publications that use other HD study datasets available through the Enroll-HD platform, please let us know if this applies to a publication of yours.

Authors

Title

Journal

Symonds AL, Macerollo A, Foy K, Alusi SH, Davies R

Genetic and environmental contributors to neurodegeneration: An exploration of the effects of alcohol on clinical features of Huntington's disease using the Enroll-HD global platform
Int J Environ Res Public Health
May 12, 2021
18 (10) :5113
PMID: 34065918

Schultz JL, Saft C, Nopoulos PC

Association of CAG repeat length in the Huntington gene with cognitive performance in young adults
Neurology
May 11, 2021
96 (19) :e2407-e2413
PMID: 33692166

Hentosh S, Zhu L, Patino J, Furr JW, Rocha NP, Furr Stimming E

Sex differences in Huntington's disease: evaluating the Enroll-HD database
Mov Disord Clin Pract
Apr 01, 2021
8 (3) :420-426
PMID: 33816672

Ogilvie AC, Gonzalez-Alegre P, Schultz JL

Diabetes mellitus is associated with an earlier age of onset of Huntington's disease
Mov Disord
Apr 01, 2021
36 (4) :1033-1034
PMID: 33368647

Oosterloo M, de Greef BTA, Bijlsma EK, Durr A, Tabrizi SJ, Estevez-Fraga C, de Die-Smulders CEM, Roos RAC

Disease onset in Huntington's disease: when is the conversion?
Mov Disord Clin Pract
Mar 31, 2021
8 (3) :352-360
PMID: 33816663
PMCID: 8015887

Cain KK, Flanigan JL, Dalrymple WA, Patrie J, Harrison MB, Barrett MJ

The effect of education on symptom onset and severity of Huntington's disease
Mov Disord Clin Pract
Mar 30, 2021
8 (4) :555-562
PMID: 33981788
PMCID: 8088098

Achenbach J, Saft C, Faissner S

Longitudinal evaluation of the effect of tricyclic antidepressants and neuroleptics on the course of Huntington's disease-data from a real world cohort
Brain Sci
Mar 25, 2021
11 (4) :413
PMID: 33805940

McLaren B, Andrews SC, Glikmann-Johnston Y, Mercieca EC, Murray NWG, Loy C, Bellgrove MA, Stout JC

Feasibility and initial validation of 'HD-Mobile', a smartphone application for remote self-administration of performance-based cognitive measures in Huntington's disease
J Neurol
Feb 01, 2021
268 (2) :590-601
PMID: 32880724

Mühlbäck A, Frank W, Klempířová O, Bezdíček O, Schmitt L, Hofstetter N, Landwehrmeyer GB, Klempíř J

Validation study of a German cognitive battery for Huntington's disease: Relationship between cognitive performance, functional decline, and disease burden
Arch Clin Neuropsychol
Jan 15, 2021
36 (1) :74-86
PMID: 32613239

Griffin BA, Booth MS, Busse M, Wild EJ, Setodji C, Warner JH, Sampaio C, Mohan A

Estimating the causal effects of modifiable, non-genetic factors on Huntington disease progression using propensity score weighting
Parkinsonism Relat Disord
Jan 13, 2021
83 :56-62
PMID: 33476879

Ranganathan M, Kostyk SK, Allain DC, Race JA, Daley AM

Age of onset and behavioral manifestations in Huntington's disease: An Enroll-HD cohort analysis
Clin Genet
Jan 01, 2021
99 (1) :133-142
PMID: 33020896

Langbehn DR, Hersch S

Clinical outcomes and selection criteria for prodromal Huntington's disease trials
Mov Disord
Dec 01, 2020
35 (12) :2193-2200
PMID: 32686867
PMCID: 7818458

Lu AT, Narayan P, Grant MJ, Langfelder P, Wang N, Kwak S, Wilkinson H, Chen RZ, Chen J, Simon Bawden C, Rudiger SR, Ciosi M, Chatzi A, Maxwell A, Hore TA, Aaronson J, Rosinski J, Preiss A, Vogt TF, Coppola G, Monckton D, Snell RG, William Yang X, Horvath S

DNA methylation study of Huntington's disease and motor progression in patients and in animal models
Nat Commun
Sep 10, 2020
11 (1) :4529
PMID: 32913184

Schultz JL, Harshman LA, Langbehn DR, Nopoulos PC

Hypertension is associated with an earlier age of onset of Huntington's disease
Mov Disord
Sep 01, 2020
35 (9) :1558-1564
PMID: 32339315

Mills JA, Long JD, Mohan A, Ware JJ, Sampaio C

Cognitive and motor norms for Huntington's disease
Arch Clin Neuropsychol
Sep 01, 2020
35 (6) :671–682
PMID: 32407458

Carlozzi NE, Boileau NR, Roberts A, Dayalu P, Hanifan DL, Miner JA, Claassen D, Provost EM

Understanding speech and swallowing difficulties in individuals with Huntington disease: Validation of the HDQLIFE Speech Difficulties and Swallowing Difficulties Item Banks
Qual Life Res
Aug 24, 2020
PMID: 32839864

Schultz JL, Moser AD, Nopoulos PC

The association between CAG repeat length and age of onset of juvenile-onset Huntington's disease
Brain Sci
Aug 20, 2020
10 (9) :E575
PMID: 32825467

Achenbach J, von Hein SM, Saft C

Functional and cognitive capacity differ in dystonic motor subtypes when compared to choreatic and hypokinetic-rigid motor subtypes in Huntington's disease
Brain Behav
Aug 01, 2020
10 (8) :e01704
PMID: 32530575
PMCID: 7428484

Kwa L, Larson D, Yeh C, Bega D

Influence of age of onset on Huntington's disease phenotype
Tremor Other Hyperkinet Mov
Jul 09, 2020
10 (21)
PMID: 32775035
PMCID: 7394225

Jaini A, Yomtoob J, Yeh C, Bega D

Understanding HD psychosis: an analysis from the Enroll-HD database
Tremor Other Hyperkinet Mov
Jul 07, 2020
10 (16)
PMID: 32775030
PMCID: 7394199

Steventon JJ, Rosser AE, Hart E, Murphy K

Hypertension, antihypertensive use and the delayed-onset of Huntington's disease
Mov Disord
Jun 30, 2020
35 (6) :937-946
PMID: 32017180
PMCID: 7317197

Yhnell E, Furby H, Lowe RS, Brookes-Howell LC, Drew CJG, Playle R, Watson G, Metzler-Baddeley C, Rosser AE, Busse ME

A randomised feasibility study of computerised cognitive training as a therapeutic intervention for people with Huntington's disease (CogTrainHD)
Pilot Feasibility Stud
Jun 19, 2020
6 :88
PMID: 32577299
PMCID: 7304172

Witkowski G, Jachinska K, Stepniak I, Ziora-Jakutowicz K, Sienkiewicz-Jarosz H

Alterations in transcranial sonography among Huntington's disease patients with psychiatric symptoms
J Neural Transm (Vienna)
Jun 16, 2020
127 (7) :1047-1055
PMID: 32285254
PMCID: 7293686

Gaßner H, Jensen D, Marxreiter F, Kletsch A, Bohlen S, Schubert R, Muratori LM, Eskofier B, Klucken J, Winkler J, Reilmann R, Kohl Z

Gait variability as digital biomarker of disease severity in Huntington's disease
J Neurol
Jun 05, 2020
267 (6) :1594-1601
PMID: 32048014
PMCID: 7293689

De Lucia N, Peluso S, Roca A, De Michele G, Trojano L, Salvatore E

Perseverative behavior on verbal fluency task in patients with Huntington's disease: a retrospective study on a large patient sample
Arch Clin Neuropsychol
Jun 02, 2020
35 (4) :358-364
PMID: 31813981

Gunn S, Maltby J, Dale M

Assessing mental health difficulties of persons with Huntington's disease: Does informant presence make a difference?
J Neuropsychiatry Clin Neurosci
Jun 01, 2020
32 (3) :244-251
PMID: 32102601

Harris KL, Kuan WL, Mason SL, Barker RA

Antidopaminergic treatment is associated with reduced chorea and irritability but impaired cognition in Huntington's disease (Enroll-HD)
J Neurol Neurosurg Psychiatry
Jun 01, 2020
91 (6) :622-630
PMID: 32229581
PMCID: 7279191

Julayanont P, Heilman KM, McFarland NR

Early-motor phenotype relates to neuropsychiatric and cognitive disorders in Huntington's disease
Mov Disord
May 02, 2020
35 (5) :781-788
PMID: 31922295

Ellis N, Tee A, McAllister B, Massey T, McLauchlan D, Stone T, Correia K, Loupe J, Kim KH, Barker D, Hong EP, Chao MJ, Long JD, Lucente D, Vonsattel JPG, Pinto RM, Elneel KA, Ramos EM, Mysore JS, Gillis T, Wheeler VC, Medway C, Hall L, Kwak S, Sampaio C, Ciosi M, Maxwell A, Chatzi A, Monckton DG, Orth M, Landwehrmeyer GB, Paulsen JS, Shoulson I, Myers RH, van Duijn E, Rickards H,…Holmans P

Genetic risk underlying psychiatric and cognitive symptoms in Huntington's disease
Biol Psychiatry
May 01, 2020
87 (9) :857-865
PMID: 32087949
PMCID: 7156911

Steventon JJ, Furby H, Ralph J, O’Callaghan P, Rosser AE, Wise RG, Busse M, Murphy K

Altered cerebrovascular response to acute exercise in patients with Huntington's disease
Brain Commun
Apr 16, 2020
2 (1) :fcaa044
PMID: 32566927
PMCID: 7293798

Fazio P, Fitzer-Attas CJ, Mrzljak L, Bronzova J, Nag S, Warner JH, Landwehrmeyer B, Al-Tawil N, Halldin C, Forsberg A, Ware J, Dilda V, Wood A, Sampaio C, Varrone A, PEARL-HD and LONGPDE10 study collaborators

PET molecular imaging of phosphodiesterase 10A: An early biomarker of Huntington's disease progressio
Mov Disord
Apr 03, 2020
35 (4) :606-615
PMID: 31967355

Goh AMY, You E, Perin S, Lautenschlager NT, Clay FJ, Loi SM, Chong T, Ames D, Chiu E, Ellis KA

Alcohol use, mental health, and functional capacity as predictors of workplace disability in a cohort with manifest Huntington's disease
J Neuropsychiatry Clin Neurosci
Feb 27, 2020
PMID: 32102602

Julayanont P, McFarland NR, Heilman KM

Mild cognitive impairment and dementia in motor manifest Huntington's disease: Classification and prevalence
J Neurol Sci
Jan 15, 2020
408 :116523
PMID: 31678902

Ciosi M, Maxwell A, Cumming SA, Hensman Moss DJ, Alshammari AM, Flower MD, Durr A, Leavitt BR, Roos RAC, TRACK-HD team, Enroll-HD team, Holmans P, Jones L, Langbehn DR, Kwak S, Tabrizi SJ, Monckton DG

A genetic association study of glutamine-encoding DNA sequence structures, somatic CAG expansion, and DNA repair gene variants, with Huntington disease clinical outcomes
EBioMedicine
Oct 10, 2019
48 :568-580
PMID: 31607598
PMCID: 6838430

Drew CJG, Quinn L, Hamana K, Williams-Thomas R, Marsh L, Dimitropoulou P, Playle R, Griffin BA, Kelson M, Schubert R, Muratori L, Reilmann R, Rosser A, Busse M

Physical activity and exercise outcomes in Huntington disease (PACE-HD): Protocol for a 12-month trial within cohort evaluation of a physical activity intervention in people with Huntington disease
Phys Ther
Sep 01, 2019
99 (9) :1201-1210
PMID: 31101920

Yomtoob J, Yeh C, Bega D

Ancillary service utilization and impact in Huntington's disease
J Huntingtons Dis
Aug 28, 2019
8 (3) :301-310
PMID: 31177235

Li F, Li K, Li C, Luo S, PREDICT-HD and ENROLL-HD Investigators of the Huntington Study Group

Predicting the risk of Huntington's disease with multiple longitudinal biomarkers
J Huntingtons Dis
Aug 27, 2019
8 (3) :323-332
PMID: 31256145
PMCID: 6718328

GeM-HD Consortium, Lee JM, Correia K, Loupe J, Kim KH, Barker D, Hong EP, Chao MJ, Long JD, Lucente D, Vonsattel JPG, Pinto RM, Abu Elneel K, Ramos EM, Mysore JS, Gillis T, Wheeler VC, MacDonald ME, Gusella JF, McAllister B, Massey T, Medway C, Stone TC, Hall L, Jones L, Holmans P, Kwak S, Ehrhardt AG, Sampaio C, Ciosi M,…Myers RH

CAG repeat not polyglutamine length determines timing of Huntington's disease onset
Cell
Aug 08, 2019
178 (4) :887-900
PMID: 31398342
PMCID: 6700281

Aubeeluck A, Stupple EJN, Schofield MB, Hughes AC, van der Meer L, Landwehrmeyer B, Ho AK

An international validation of a clinical tool to assess carers' quality of life in Huntington's disease
Front Psychol
Jul 23, 2019
10 :1658
PMID: 31402885
PMCID: 6676956

Zeitler B, Froelich S, Marlen K, Shivak DA, Yu Q, Li D, Pearl JR, Miller JC, Zhang L, Paschon DE, Hinkley SJ, Ankoudinova I, Lam S, Guschin D, Kopan L, Cherone JM, Nguyen HB, Qiao G, Ataei Y, Mendel MC, Amora R, Surosky R, Laganiere J, Vu BJ, Narayanan A, Sedaghat Y, Tillack K, Thiede C, Gärtner A, Kwak S, Bard J,…Zhang HS

Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington's disease
Nat Med
Jul 01, 2019
25 (7) :1131-1142
PMID: 31263285